PT Royal Medicalink Pharmalab
Vipalbumin® Plus
Packaging Specifications

Box, 3 Blisters @ 10 Capsules (Total 30 Capsules)

Official BPOM License

POM TR182312681

Medical SupplementVipalbumin GroupPT Royal Medicalink Pharmalab

Vipalbumin® Plus

Fitofarmaka Synergy of Snakehead Fish Albumin + Curcuma for Comprehensive Recovery & Appetite

Product Overview

Vipalbumin® Plus is a comprehensive fitofarmaka innovation combining premium pure snakehead fish albumin fractions (Channa striata) with standardized Curcuma extract (Curcuma xanthorrhiza) and natural bioflavonoids. Specifically formulated to accelerate surgical wound healing while simultaneously enhancing digestive appetite and restoring overall metabolic vitality in post-hospitalized patients.

Key Health Benefits & Therapeutic Indications

Key Therapeutic Benefits:
- Accelerates recovery of major surgical incisions, cesarean sections, trauma wounds, and burns.
- Rapidly elevates serum albumin levels in hypoalbuminemic conditions.
- Stimulates appetite and enhances intestinal nutrient absorption during convalescence.
- Supports digestive gastrointestinal function and provides natural hepatoprotective defense.
- Strengthens systemic immunity and nutritional status in oncology and chronic care patients.

Detailed Composition & Active Ingredients

Active Ingredients per Capsule (500 mg):
- Fractionated Channa striata Extract (Pure Bio-Albumin): 350 mg
- Curcuma xanthorrhiza Extract (Standardized Curcuminoids): 100 mg
- Citrus sinensis Extract (Natural Bioflavonoids & Vitamin C): 50 mg
- Complete Essential Amino Acids & Organic Zinc (Zn) Matrix

Dosage & Administration Guidelines

Post-Surgery & Hypoalbuminemia Therapy: 2 - 3 times daily 1 - 2 capsules after meals.
Convalescence & Appetite Stimulation: 2 times daily 1 capsule after meals.
Daily Health Maintenance: 1 capsule once daily.

Clinical Research & Quality Assurance

Clinical trials demonstrate the synergy of fractionated albumin and standardized curcuminoids delivers 1.3x faster plasma albumin restoration with an 82% improvement in patient appetite scores within 10 days of adjunctive therapy.